This book provides a brief outlook of the need and potential market opportunities of biomarkers for brain injury, focusing particularly on Schizophrenia. This debilitating disorder affects millions worldwide, with limited levels of diagnostic and prognostic methods. Breakthroughs in imaging technologies coupled with traditional diagnostic methods may have the potential to discover biomarkers, that are specific for the disease. Such discoveries of biomarkers may have a number of positive future implications in the rapid diagnosis and eventual treatment of the brain injury.